Raigmore Hospital is a health facility located in Inverness, Scotland. It serves patients from the local area as well as providing specialist services to patients from across the Highland area.

There are 452 beds in Raigmore Hospital.

During the past decade, Raigmore Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 8 clinical trials were completed, i.e. on average, 29.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Raigmore Hospital" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Scottish Cancer Therapy Network" with 4 trials sponsored, "University College, London" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Institute of Cancer Research, United Kingdom" with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Raigmore Hospital" #1 collaborator was "Cancer Research UK" with 10 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 3 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator and "Takeda" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Raigmore Hospital" are "Breast Cancer" (12 trials), "Lymphoma" (4 trials), "Fallopian Tube Cancer" (3 trials), "Lung Cancer" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Raigmore Hospital" in a lesser frequency.

Most popular intervention types in "Raigmore Hospital" are "Drug" (47 trials), "Procedure" (15 trials), "Biological" (10 trials), "Radiation" (10 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (11 trials), "radiation therapy" (8 trials), "fluorouracil" (7 trials), "methotrexate" (6 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Raigmore Hospital" are 51 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Raigmore Hospital". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Raigmore Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Raigmore Hospital, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".